|
|
|||||||||||||||||||||||||||||||||||||||||
SurveyShould regulation of direct to consumer genetic testing be increased?BioFact:(1920) - The human growth hormone is discovered by Evans and Long. |
HDMA’s Looking Forward in Reverse Logistics Healthcare Seminar - Sept. 22-23 - Dallas, TX |
||||||||||||||||||||||||||||||||||||||||
CEO Reading ListJanice M. LeCocq, Ph.D.Partner Collins Mabry & Co., L.L.C. San Francisco, CA Biography Dr. Janice M. LeCocq is a partner of Collins Mabry & Co., L.L.C., a San Francisco based consulting company. Dr. LeCocq is the former Chair and Chief Executive Officer of Gryphon Sciences. Prior to joining Gryphon in December 1994, Dr. LeCocq was Executive Vice President of Finance and Administration at ICOS Corporation in Seattle, Washington, and was previously a General Partner in Corporate Finance at Montgomery Securities, a leading investment banker for emerging growth companies. Dr. LeCocq also serves as a Director of Hyseq, and was previously a Director of ICOS Corporation and Molecular Dynamics. Education: Ph.D. Anthropology (Stanford University), AB Human Biology (Stanford University). Company Profile Collins Mabry & Co., L.L.C., is a San Francisco based company that provides consulting and advisory services to investors and entrepreneurs in the life sciences and health care industry. Collins Mabry provide due diligence assistance for potential new investments, strategic positioning and operational assistance for new businesses, and pragmatic, hands-on assistance in problem situations. Jan LeCocq's Suggested Reading List
Jan's Personal Favorites
We welcome your feedback and comments. |
|||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||